50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,655.04 (-1.03%)
DOW   29,260.81 (-1.11%)
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.30 (-0.26%)
META   136.37 (-2.88%)
GOOGL   98.17 (-0.58%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.87 (-2.46%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.14 (-3.25%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
S&P 500   3,655.04 (-1.03%)
DOW   29,260.81 (-1.11%)
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.30 (-0.26%)
META   136.37 (-2.88%)
GOOGL   98.17 (-0.58%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.87 (-2.46%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.14 (-3.25%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
S&P 500   3,655.04 (-1.03%)
DOW   29,260.81 (-1.11%)
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.30 (-0.26%)
META   136.37 (-2.88%)
GOOGL   98.17 (-0.58%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.87 (-2.46%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.14 (-3.25%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
S&P 500   3,655.04 (-1.03%)
DOW   29,260.81 (-1.11%)
QQQ   274.37 (-0.41%)
AAPL   150.77 (+0.23%)
MSFT   237.30 (-0.26%)
META   136.37 (-2.88%)
GOOGL   98.17 (-0.58%)
AMZN   115.15 (+1.20%)
TSLA   276.01 (+0.25%)
NVDA   122.28 (-2.30%)
NIO   17.62 (-0.11%)
BABA   78.91 (+0.14%)
AMD   66.30 (-2.44%)
T   15.67 (-2.12%)
MU   48.87 (-2.46%)
CGC   2.74 (-3.52%)
F   11.99 (-2.60%)
GE   64.35 (-0.31%)
DIS   98.12 (-1.39%)
AMC   6.83 (-14.52%)
PYPL   84.14 (-3.25%)
PFE   43.83 (-0.57%)
NFLX   224.07 (-1.03%)
OTCMKTS:ISCO

International Stem Cell - ISCO Stock Forecast, Price & News

$0.35
-0.05 (-12.60%)
(As of 09/23/2022 08:57 PM ET)
Add
Compare
Today's Range
$0.29
$0.35
50-Day Range
$0.31
$0.45
52-Week Range
$0.25
$0.56
Volume
700 shs
Average Volume
4,041 shs
Market Capitalization
$2.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ISCO stock logo

About International Stem Cell (OTCMKTS:ISCO) Stock

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. The company sells skincare products through a website and professional channels; and human cell culture products through its sales force, OEM partners, and brand distributors. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.

Receive ISCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter.

ISCO Stock News Headlines

International Stem Cell Corp.
India Stem Cell Markets, Competition Forecast & Opportunities, 2026
See More Headlines
Receive ISCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter.

ISCO Company Calendar

Last Earnings
5/17/2019
Today
9/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ISCO
CUSIP
460378102
Employees
33
Year Founded
N/A

Profitability

Net Income
$-900,000.00
Pretax Margin
-6.82%

Debt

Sales & Book Value

Annual Sales
$7.18 million
Book Value
($0.57) per share

Miscellaneous

Free Float
1,744,000
Market Cap
$2.80 million
Optionable
Not Optionable
Beta
0.78

Key Executives

  • Dr. Andrey Semechkin Ph.D. (Age 62)
    Co-Chairman & CEO
    Comp: $58.1k
  • Dr. Russell Kern Ph.D. (Age 36)
    Exec. VP, Chief Scientific Officer, Principal Financial Officer & Director
    Comp: $58.1k
  • Ms. Rebecca McGee M.B.A.
    Pres of Lifeline Cell Technology













ISCO Stock - Frequently Asked Questions

How have ISCO shares performed in 2022?

International Stem Cell's stock was trading at $0.47 at the start of the year. Since then, ISCO stock has decreased by 25.6% and is now trading at $0.3496.
View the best growth stocks for 2022 here
.

Are investors shorting International Stem Cell?

International Stem Cell saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 4,000 shares, an increase of 1,900.0% from the August 15th total of 200 shares. Based on an average daily volume of 5,700 shares, the short-interest ratio is currently 0.7 days.
View International Stem Cell's Short Interest
.

How were International Stem Cell's earnings last quarter?

International Stem Cell Co. (OTCMKTS:ISCO) posted its quarterly earnings data on Friday, May, 17th. The biotechnology company reported ($0.12) earnings per share for the quarter. The biotechnology company had revenue of $2.22 million for the quarter.

What other stocks do shareholders of International Stem Cell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other International Stem Cell investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Athersys (ATHX), Turkcell Iletisim Hizmetleri A.S. (TKC), Biocept (BIOC), Capricor Therapeutics (CAPR), Neuralstem (CUR), FuelCell Energy (FCEL) and Gulf Keystone Petroleum (GKP).

What is International Stem Cell's stock symbol?

International Stem Cell trades on the OTCMKTS under the ticker symbol "ISCO."

How do I buy shares of International Stem Cell?

Shares of ISCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is International Stem Cell's stock price today?

One share of ISCO stock can currently be purchased for approximately $0.35.

How much money does International Stem Cell make?

International Stem Cell (OTCMKTS:ISCO) has a market capitalization of $2.80 million and generates $7.18 million in revenue each year. The biotechnology company earns $-900,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis.

How can I contact International Stem Cell?

International Stem Cell's mailing address is 5950 PRIESTLY DRIVE, CARLSBAD CA, 92008. The official website for the company is www.internationalstemcell.com. The biotechnology company can be reached via phone at (760) 940-6383, via email at ir@intlstemcell.com, or via fax at 760-476-0600.

This page (OTCMKTS:ISCO) was last updated on 9/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.